Koxma-CC Syrup

Introduction

Koxma-CC is a prescription medication that combines four active ingredients: Ambroxol, Cetirizine, Dextromethorphan Hydrobromide, and Phenylephrine. This medication is commonly prescribed to relieve symptoms associated with respiratory tract infections and allergic conditions.

Uses

Koxma-CC is primarily used to alleviate symptoms associated with respiratory tract infections, such as cough, congestion, and excess mucus production. It is also prescribed to provide relief from allergic conditions, including hay fever and allergic rhinitis.

Dosage and Administration

The recommended dosage of Koxma-CC may vary depending on the age, weight, and severity of symptoms. Follow the instructions provided by your healthcare professional. Generally, the syrup is taken orally, with or without food. Shake the bottle well before use and use the measuring device provided to ensure accurate dosage.

Mechanism of Action

Ambroxol, one of the active ingredients in Koxma-CC, works by reducing the viscosity of mucus, making it easier to cough up and clear the airways. Cetirizine is an antihistamine that helps relieve symptoms of allergies by blocking the effects of histamine, a substance released during allergic reactions. Dextromethorphan Hydrobromide is a cough suppressant that acts on the cough center in the brain to reduce coughing. Phenylephrine is a decongestant that works by narrowing blood vessels, thereby reducing nasal congestion.

Side Effects

Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. If any of these side effects persist or worsen, it is advisable to consult your healthcare professional.

Serious side effects are rare but can occur. Seek immediate medical attention if you experience symptoms such as difficulty breathing, chest tightness, rapid heartbeat, severe dizziness, or skin rash.

Drug Interactions

Koxma-CC may interact with certain medications, including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and other medications that can cause drowsiness. Inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid any potential drug interactions.

Precautions

Before taking Koxma-CC, inform your healthcare professional if you have any known allergies or sensitivities to any of the active ingredients or other medications. This medication may not be suitable for individuals with certain medical conditions, such as glaucoma, high blood pressure, heart disease, or thyroid problems. Discuss your medical history with your healthcare professional before starting this medication.

Storage

Koxma-CC should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed when not in use. Do not freeze the syrup. Keep it out of reach of children and pets.

Patient Tips

• Follow the dosage instructions provided by your healthcare professional and use the measuring device provided for accurate dosing.
• If you experience drowsiness, avoid activities that require alertness, such as driving or operating machinery.
• Stay well-hydrated by drinking plenty of fluids, unless otherwise advised by your healthcare professional.
• If you have any questions or concerns about the medication or its use, do not hesitate to consult your healthcare professional for clarification.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Cetirizine: antihistamine that relieves allergy symptoms (NHS UK) [Accessed 22 Jun. 2024] (online) Available at:
• allacan 10mg film-coated tablets (Health Professionals SmPC) Available at:
• Ambroxol (Drugs.com) [Accessed 30 Jun. 2024] (online) Available at:
• all day allergy relief (cetirizine) 10 mg tablet (OTC) [Accessed 20 Jun. 2024] (online) Available at:
• Cetirizine (MedlinePlus) [Accessed 6 Jun. 2024] (online) Available at:
• Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1119-29. doi: 10.1517/17425255.4.8.1119. [Accessed 27 Jun. 2024] Available at: